Stress Urinary Incontinence
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with participation in following clinical study in Nagoya University Hospital -UMIN000006116 -UMIN000017901 and NCT02529865 2)Patients who are able to collect additional 100g fat 3)Male: age of 20 or above Female: age of 40 or above 4)Patients who are willing and able to give signed consent
Exclusion criteria
Exclusion criteria: 1)Patients who are not able to participate in following clinical study in Nagoya University Hospital -UMIN000006116 -UMIN000017901 and NCT02529865 2)Any other patients whom the study investigator deemed ineligible to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Cell count of ADRCs 2)Characterization of ADRCs by flow cytometry 3)Cytokine production of ADRCs 4)CFU assay of ADRCs 5)Differentiation into smooth muscle of ADRCs 6)Cytokine production of Urine 7)Relationship between 1)-6) and clinical study results. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Influence on soft agar colony formation assay of ADRCs 2)Effect on tumor cells of ADRCs 3)Exploring the method for cell culture and preservation of ADRCs | — |
Countries
Japan
Contacts
Nagoya University Hospital Center for Advanced Medicine and Clinical Research